A review of computational studies and bioinformatics analysis of effective drug as an inhibitor against EGFR/VEGFR-2 kinases

Synthesis, anticancer properties, and molecular modeling of novel thiazolyl-pyrazolone derivatives conjugated with tetrahydronaphthalene as anticancer agents with potential VEGFR

Molecular Modeling, Breast Cancer, and Hepatitis A, B, C Molecular Docking Investigation of (2E)-1-phenyl-butane-1,2,3-trione 2-[(2-oxo-2H-chromene-6-yl)hydrazone]

Design, synthesis and antiproliferative evaluation of novel pyrazolo-pyrimidine derivatives with expected cyclin-dependent kinase 2 inhibitory effect

VEGFER-2 INHIBITORS AND QUINAZOLINE-BASED ANTICANCER AGENTS

Facile Synthesis, Inhibition of VEGFR-2, Anticancer activity, Molecular Dynamics Simulation and Target Identification of Some New Pyrano thiazine derivatives

Synthesis, Biological Evaluation and Molecular Docking Studies of Newly Synthesized 4- Amino Quinazoline Derivatives as Potential Multitarget Anticancer Agents.

Molecular Docking Approach of Some Quinoxaline Derivatives as Anticancer Agents Targeting VEGFR-2.

In Vitro Anticancer Potentiality and Molecular Modelling Study of Novel Cyclic Pentapeptides based on 1, 2-benzenedicarbonyl chloride

Synthesis, cytotoxicity assessment and molecular docking of novel thienyl-pyrazoles as VEGFR2 Inhibitors.